immuno-oncology

Servier and Aqemia announce the extension of their new-molecule discovery collaboration on an undruggable therapeutic target in immuno-oncology.…

Kiromic BioPharma, Inc. a clinical-stage biotherapeutics company using its proprietary DIAMOND AI (artificial intelligence) and data mining platform…

In Vivo Preclinical Data Expected to Enable Three New IND Applications to Evaluate Company’s Gamma Delta T cell Product Candidates Procel, Isocel,…

Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through the development of potentially best-in-class IL-2…

Axion BioSystems, a leading life sciences tools company focused on advanced live-cell assay systems, announces the acquisition of the…

New data demonstrate eradication of solid tumors in preclinical study Aulos Bioscience, an immuno-oncology company working to revolutionize…

Agreement grants a license to Exact Sciences for OncXerna's Xerna™ TME Panel adding to its comprehensive tumor profiling solution, GEM ExTra®…

- Potential to bring in-house cell-based therapies that potentiate checkpoint inhibitors Immunomic Therapeutics, Inc., (“ITI”) a privately held…